Gratus Capital’s PAVmed PAVM Stock Holding History

Gratus Capital’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24	Closed	-$15K	–	207
2022 Q1	$15K	Hold	24	–	–	﹤0.01%	201
2021 Q4	$27K	Hold	24	–	–	﹤0.01%	204
2021 Q3	$94K	Hold	24	–	–	0.01%	188
2021 Q2	$70K	Hold	24	–	–	0.01%	185
2021 Q1	$49K	Hold	24	–	–	0.01%	181
2020 Q4	$23K	Hold	24	–	–	﹤0.01%	183
2020 Q3	$20K	Hold	24	–	–	﹤0.01%	167
2020 Q2	$23K	Buy	+24	New	+$24K	﹤0.01%	162

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gratus Capital's PAVM Position: Q2 2022 in Review

Gratus Capital sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 24 shares — an estimated $15K sold.

Gratus Capital first reported a position in PAVM in Q2 2020 and held it in 8 quarters. The position peaked at $94K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

Gratus Capital reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
Gratus Capital sold 24 PAVmed shares in Q2 2022, an estimated $15K.
Gratus Capital first reported a position in PAVmed in Q2 2020 and held it in 8 quarters.
Gratus Capital's PAVmed position peaked at $94K in Q3 2021.
73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Gratus Capital's 13F filing for Q2 2022, filed 29 Jul 2022.